Adcock $1.2 Billion Sale To CFR Hits Another S. Africa Pension Fund Snag
This article was originally published in PharmAsia News
Executive Summary
Adcock Ingram's proposed $1.2 billion sale to Chile's CFR Pharmaceuticals hit another snag when South Africa's pension fund and largest stakeholder said it would not sell its shares to a recent white knight.